Literature DB >> 7220406

Plasma and salivary concentrations of erythromycin after administration of three different formulations.

J Henry, P Turner, M Garland, F Esmieu.   

Abstract

In a 6-volunteer cross-over study the pharmacokinetics of 3 erythromycin preparations were compared. A single oral dose of 500 mg of each preparation was administered at each occasion and the levels measured in timed samples of plasma and saliva. Markedly higher blood concentrations of the estolate and propionate were obtained compared to the stearate. Comparison of serum and plasma concentration of the drugs from each split sample showed no significant differences. Plasma concentrations always exceeded those in saliva but for any one preparation a similar ratio was obtained at different times. This may be useful to ascertain compliance and to measure concentration of the compounds where direct measurement in plasma is not practicable.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7220406      PMCID: PMC2426034          DOI: 10.1136/pgmj.56.660.707

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

1.  Serum protein binding of erythromycin and erythromycin 2'-propionate ester.

Authors:  R G Wiegand; A H Chun
Journal:  J Pharm Sci       Date:  1972-03       Impact factor: 3.534

2.  A study of the behavior of propionyl erythromycin in blood by a new chromatographic method.

Authors:  V C Stephens; C T Pugh; N E Davis; M M Hoehn; S Ralston
Journal:  J Antibiot (Tokyo)       Date:  1969-11       Impact factor: 2.649

Review 3.  A new look at erythromycin.

Authors:  R W Lacey
Journal:  Postgrad Med J       Date:  1977-04       Impact factor: 2.401

4.  Antibacterial activity of 2'-esters of erythromycin.

Authors:  P L Tardrew; J C Mao; D Kenney
Journal:  Appl Microbiol       Date:  1969-08
  4 in total
  3 in total

1.  Should erythromycin dose be altered in haemodialysis patients?

Authors:  A Iliopoulou; K Downey; D M Chaput de Saintonge; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 2.  A Qualitative Review on the Pharmacokinetics of Antibiotics in Saliva: Implications on Clinical Pharmacokinetic Monitoring in Humans.

Authors:  Tony K L Kiang; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2016-03       Impact factor: 6.447

3.  Erythromycin versus neomycin in the treatment of hepatic encephalopathy in cirrhosis: a randomized double-blind study.

Authors:  Fernando Gomes Romeiro; Fabio da Silva Yamashiro; Madileine Francely Américo; Luciana Aparecida Corá; Giovanni Faria Silva; José Ricardo de Arruda Miranda; Carlos Antonio Caramori
Journal:  BMC Gastroenterol       Date:  2013-01-16       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.